 CAMBRIDGE, Mass., Feb. 18, 2021 GLOBE NEWSWIRE -- Generation Bio Co. Nasdaq: GBIO, an innovative genetic medicines company creating a new class of gene therapy, announced today that Ron Cooper has been appointed to its Board of Directors. The appointment is effective March 1, 2021. 